Arkolith/Insider Trading/PTGX/Form 4

Selick Harold E

DirectorProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Mar 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.5M
Net Open-Market Flow
-$2.5M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)24K$105.00$2.5M61K
Mar 26, 2026Option exercise(M)24K$12.88$309K85K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2026Option exercise(M)24K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-036318) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML